Issue navigation
Volume 78, Issue 9, September 2023
Reviews
Advances in antibacterial treatment of adults with high-risk febrile neutropenia
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2109–2120, https://doi.org/10.1093/jac/dkad166
The risk-benefit balance of resistance to ionophores in Enterococcus faecium and Enterococcus faecalis for ionophore coccidiostats in broiler chickens
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2121–2130, https://doi.org/10.1093/jac/dkad183
Systematic Review
Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2131–2139, https://doi.org/10.1093/jac/dkad216
Original Research
Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2140–2147, https://doi.org/10.1093/jac/dkad192
The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2148–2161, https://doi.org/10.1093/jac/dkad196
Novel antibiotic susceptibility of an RNA polymerase α-subunit mutant in Pseudomonas aeruginosa
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2162–2169, https://doi.org/10.1093/jac/dkad207
Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2170–2174, https://doi.org/10.1093/jac/dkad211
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2175–2184, https://doi.org/10.1093/jac/dkad215
CHROMAgar™ LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients—a multicentre study approach, 2021–2022
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2185–2191, https://doi.org/10.1093/jac/dkad218
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2192–2202, https://doi.org/10.1093/jac/dkad219
Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2203–2208, https://doi.org/10.1093/jac/dkad221
Impact of veterinary antibiotics on plasmid-encoded antibiotic resistance transfer
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2209–2216, https://doi.org/10.1093/jac/dkad226
Hospitalizations and severe complications following acute sinusitis in general practice: a registry-based cohort study
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2217–2227, https://doi.org/10.1093/jac/dkad227
Pseudomonas aeruginosa increases the susceptibility of Candida albicans to amphotericin B in dual-species biofilms
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2228–2241, https://doi.org/10.1093/jac/dkad228
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2242–2253, https://doi.org/10.1093/jac/dkad229
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2254–2262, https://doi.org/10.1093/jac/dkad230
Surveillance of antimicrobial resistant Shiga toxin-producing E. coli O157:H7 in England, 2016–2020
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2263–2273, https://doi.org/10.1093/jac/dkad231
Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017–2019
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2274–2282, https://doi.org/10.1093/jac/dkad232
Diagnostic and antibiotic stewardship lessons: an outpatient assessment of symptomatic reflex urinalysis ordering accuracy using an electronic best-practice alert
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2283–2290, https://doi.org/10.1093/jac/dkad233
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2291–2296, https://doi.org/10.1093/jac/dkad234
Assessing the conversion of electronic medical record data into antibiotic stewardship indicators
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2297–2305, https://doi.org/10.1093/jac/dkad235
Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2306–2314, https://doi.org/10.1093/jac/dkad236
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2315–2322, https://doi.org/10.1093/jac/dkad237
Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2323–2334, https://doi.org/10.1093/jac/dkad240
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2335–2342, https://doi.org/10.1093/jac/dkad241
Imipenem/funobactam (formerly XNW4107) in vivo pharmacodynamics against serine carbapenemase-producing Gram-negative bacteria: a novel modelling approach for time-dependent killing
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2343–2353, https://doi.org/10.1093/jac/dkad242
Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2354–2360, https://doi.org/10.1093/jac/dkad245
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2361–2365, https://doi.org/10.1093/jac/dkad247
Novel SCCmec variants in clonal complex 398 and lineage-specific pseudo-SCCmec identified in ST88 MRSA from invasive bloodstream infections in China
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2366–2375, https://doi.org/10.1093/jac/dkad250
Research Letters
HIV-1 RNA levels in semen of people on ‘short-cycle’ antiretroviral therapy
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2376–2377, https://doi.org/10.1093/jac/dkad197
Meropenem/vaborbactam plus aztreonam for the treatment of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae infections
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2377–2379, https://doi.org/10.1093/jac/dkad206
ICE-borne erm(T)-mediated macrolide resistance in Mannheimia haemolytica
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2379–2381, https://doi.org/10.1093/jac/dkad209
Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2382–2384, https://doi.org/10.1093/jac/dkad210
Letter to the Editor
Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections—authors’ response
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2385–2386, https://doi.org/10.1093/jac/dkad217
